N-butyl cyanoacrylate in the treatment of venous insufficiency - the effect of embolisation with ablative polymerisation

VASA ◽  
2016 ◽  
Vol 45 (3) ◽  
pp. 241-246 ◽  
Author(s):  
Eyüp Serhat Çalık ◽  
Ümit Arslan ◽  
Fırat Ayaz ◽  
Mehmet Tort ◽  
Ziya Yıldız ◽  
...  

Abstract. Background: The primary objective of this multicentre prospective observational study was to evaluate the early results of a new non-thermal embolisation method using N-butyl cyanoacrylate in venous insufficiency. Patients and methods: A total of 181 patients with a varicose vein diagnosis were treated with the VariClose: Vein Sealing Systems at four different centres. The protocol included physical and colour Doppler ultrasonography examination, venous clinical severity score and quality of life assessment before and after the procedure on days 1 and 7 and at months 1, 3 and 6. Clinical recovery was evaluated by comparing the venous clinical severity score and the quality of life assessment before and after the procedure. Results: In total, 215 embolisation procedures were successfully completed on 181 patients (110 female) with a mean age of 37.6 ± 13.2 years (range 18 - 72 years). The 215 procedures consisted of 25 bilateral applications on 206 great saphenous veins and 9 small saphenous veins. The average pre-interventional diameter of great saphenous veins was 6.5 ± 1.4 mm (4.3 - 14 mm), and the mean diameter of small saphenous veins was 5.2 ± 1.3 mm (3.8 - 8.6 mm). The average length of the sealed vein segments was 31.6 ± 6.1 cm (23 - 70 cm), and the average N-butyl cyanoacrylate usage for the patient was 0.9 ml (0.7 - 2.1 ml). The procedural occlusion rate was 100 %. Post-operative pain was observed in 11 patients (6.1 %), and thrombophlebitis was observed in 1 patient (0.5 %). No total recanalisation was observed. Five (2.7 %) partial recanalisations were observed at the 6 month follow-up. The 6 month total occlusion rate was 97.2 %. Conclusions: This new tumescent-free non-thermal embolisation method can be applied safely with high success rates.

2011 ◽  
Vol 127 (2) ◽  
pp. AB226-AB226
Author(s):  
M. Kwofie-Mensah ◽  
R.J. Green ◽  
R. Masekela ◽  
O. Kitchin ◽  
T. Moodley

2013 ◽  
Vol 149 (2_suppl) ◽  
pp. P271-P271
Author(s):  
Silvia C. A. S. B. Beilke ◽  
Isabele F. C. Peccini ◽  
Fabio T. M. Lorenzetti

2017 ◽  
Vol 33 (6) ◽  
pp. 388-396 ◽  
Author(s):  
Mert Dumantepe ◽  
Ibrahim Uyar

Objective To evaluate the clinical safety and effectiveness of percutaneous rheolytic thrombectomy in patients with acute lower extremity deep venous thrombosis. Method Sixty-eight consecutive patients with acute massive lower extremity deep venous thrombosis were included in this retrospective study. A percutaneous rheolytic thrombectomy device (Angiojet ® Rheolytic thrombectomy catheter, Boston Scientific, Marlborough, MA, USA) was used in all patients in an angiography suite through ipsilateral popliteal vein access. Thrombus clearance and complications were evaluated. Furthermore, patients underwent a clinical evaluation according to a modified Villalta scale for the investigation of post thrombotic syndrome in follow-up. The Venous Clinical Severity Score, Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Sym questionnaires were completed preoperatively and readministered postoperatively. Results Overall thrombus clearance (complete recanalization was achieved in 58 patients (85.2%) and partial recanalization was achieved in 7 patients (10.2%) confirmed through venographic assessment was achieved in 95.5% of the patient population. The mean Venous Clinical Severity Score preoperatively was 13.1 ± 2.2 and decreased to 4.0 ± 1.3 postoperatively (P < 0.01). The Villalta scale dropped from 12.9 ± 2.8 to 5.5 ± 1.4 postoperatively (P < 0.001). Overall quality of life and symptoms improved as assessed by Venous Insufficiency Epidemiological and Economic Study-Quality of Life/Sym (P < 0.01 and 0.02, respectively). Only three minor bleedings were seen but none of the patients suffered from major bleeding, symptomatic pulmonary embolism, death, or other procedure related complications. Fifty-nine out of 65 patients (90.7%) who were treated successfully with rheolytic thrombectomy remained patent at 12 months according to DUS and five patients (7.3%) developed a mild post thrombotic syndrome. Conclusion Rheolytic thrombectomy with or without stenting is superior to anticoagulant therapy alone in terms of both ensuring venous patency and improving clinical symptoms. This technique is a safe, effective and easily performed method of endovascular treatment with a low rate of major treatment complications and shows promising clinical mid-term results.


Author(s):  
Stana Pačarić ◽  
Tajana Turk ◽  
Ivan Erić ◽  
Želimir Orkić ◽  
Anamarija Petek Erić ◽  
...  

The aim of this study was to examine the quality of life and to report on the utility and QALY measures in patients before and after coronary artery bypass grafting (CABG); to investigate whether the SF-12 is comparable with the SF-36 for measuring health-related quality of life of patients with CABG; and to determine the impact of individual predictors on poor quality of life assessment after rehabilitation. This prospective study was conducted between January 2017 and December 2018 at the University Hospital Center Osijek, at three time points: pre-operation, 1 month after surgery, and after rehabilitation. The study was conducted with the SF-36 and SF-12 health questionnaires on 47 participants. After rehabilitation, there was a significant improvement in all domains of quality of life. The highest score was given to the change in pain (BP); mean scores were 63.8 (95% CI 56.9 to 70.6) (p = 0.001). The lowest grade (the lowest quality) after rehabilitation was in the domain of limitations due to physical difficulties (RP); arithmetic mean was 48.5 (95% CI 41 to 55.9) (p < 0.001). Quality-adjusted life-year was 0.41 (95% CI 0.38–0.44) after the CABG. The results of this study show that patients with coronary heart disease have poor quality of life before surgery. One month after the surgery, the quality of life improved, but was still inadequate. One year after surgery, satisfactory results were obtained in almost all subscales. The SF-36, SF-12, and its components, can be used effectively in patients with CABG. Age, gender, lifestyle, and risk factors in our sample of participants are not predictors of poor quality of life assessment after rehabilitation.


2003 ◽  
Vol 25 (1) ◽  
pp. 298-308 ◽  
Author(s):  
Anna Campanati ◽  
Luca Penna ◽  
Teresa Guzzo ◽  
Lucia Menotta ◽  
Barbara Silvestri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document